Breaking News, Promotions & Moves

Genezen Appoints New CEO as GMP Expansion Begins

Ray Kaczmarek takes the helm of the cell and gene therapy CDMO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genezen Inc., a cell and gene therapy contract development and manufacturing organization (CDMO), has appointed Ray Kaczmarek as CEO.   Mr. Kaczmarek has more than 28 years of leadership experience with the past 20 years in pharmaceutical and biotechnology manufacturing and supply chain operations.   The past seven years he has served in various roles at the executive level with the most recent roles being senior vice president of good manufacturing practice (GMP) operations at TriLink Biotechno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters